Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Vertex Pharmaceuticals Incorporated
FDA Inspection
•Vertex Pharmaceuticals Incorporated•September 7, 2017

Vertex Pharmaceuticals Incorporated – FDA Inspection, Sep 7, 2017

Record Details

This FDA Inspection record concerns Vertex Pharmaceuticals Incorporated, with an inspection on September 7, 2017, issued by the New England District Office, covering human drugs.

Company
Vertex Pharmaceuticals Incorporated
Inspection Date
September 7, 2017
Product Type
Human Drugs
Office
New England District Office
People
  • Christina A. Capacci-Daniel (Issuing Officer)
  • Sean R. Marcsisin (FDA Associated Person)
  • Sharmista Chatterjee (Issuing Officer)
  • Yong Hu (Issuing Officer)
View Company Profile

ID · b28bfc95-4c50-4ca9-99d0-5d6d7d7b88e2

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1024312
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

3
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.160(a)Deviations from laboratory control requirements

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Vertex Pharmaceuticals Incorporated

14
DateClassificationOfficeProject area
July 31, 2026Not classifiedNew England District Office
March 3, 2026NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 1, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
May 4, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 19, 2022NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 14 other inspections on the company page
Other documents for Vertex Pharmaceuticals Incorporated
  • FDA Inspection 1333028 - 2026-07-31
  • FDA Inspection 1306258 - 2026-03-03
  • FDA Inspection 1246447 - 2024-08-01
  • FDA Inspection 1205834 - 2023-05-04
  • FDA Inspection 1180001 - 2022-08-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vertex Pharmaceuticals Incorporated
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.